- Naranj Research Desk
- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
4% – 5%
10 - 12 Days
4% – 5%
10 - 12 Days
RMD — NYSE —
Current RSI of this stock is 77.69, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our US stock market signals, ResMed stock price target will be USD 288 - USD 290 in the next 10-12 trading sessions.
4% – 5%
10 - 12 Days
4% – 5%
10 - 12 Days
ResMed Inc., founded in 1989 and headquartered in San Diego, develops and sells medical devices and cloud-based software focused on treating respiratory conditions like sleep apnea. The company operates through two main segments: Sleep and Respiratory Care, and Software as a Service (SaaS). Its medical device offerings include portable diagnostic tools such as ApneaLink Air and NightOwl, along with cloud-based platforms like AirView for remote patient monitoring and myAir for personalized therapy support. ResMed also provides digital solutions like U-Sleep and Propeller to help track and manage patient compliance. Through its SaaS segment, the company offers business and care management software such as Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, serving home health agencies, senior care facilities, and other out-of-hospital care providers. ResMed markets its products through a global network of distributors and a direct sales force, serving sleep clinics, hospitals, and home healthcare providers.
RMD — NYSE —
Current RSI of this stock is 77.69, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our US stock market signals, ResMed stock price target will be USD 288 - USD 290 in the next 10-12 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
